Sign in Subscribe
Chronic kidney failure

Chronic Kidney Disease Research Highlights Importance of Polypharmacy Adherence

Strategic Insights

— 1 min read

Researchers at Universidade Federal do Para have emphasized the significance of treating chronic kidney disease (CKD) with complex pharmacological management. A study conducted with 52 patients at a regional hospital in northern Brazil revealed that 65% of patients presented moderate adherence, while 35% exhibited low adherence to medication, which was significantly associated with lower quality-of-life scores, particularly in the physical and psychological domains. Statistical analysis suggested that female sex, higher educational level, and recent diagnosis (1-3 years) were predictors of better adherence.

Key Takeaways:

  • The study highlighted the negative impact of low adherence to pharmacotherapy on the quality of life of patients with CKD.
  • 65% of patients in the study had moderate adherence to medication, while 35% had low adherence.
  • Low adherence was significantly associated with lower quality-of-life scores, particularly in the physical and psychological domains.
  • Female sex, higher educational level, and recent diagnosis (1-3 years) were predictors of better adherence.
  • Targeted interventions, including individualized pharmacotherapy review, health education programs, and psychosocial support, were recommended to improve adherence and promote patient well-being.
  • The study demonstrated the importance of critically examining polypharmacy and its effects on CKD patients.

Statistics:

  • 52 patients with CKD were included in the study.
  • 65% of patients presented moderate adherence, while 35% exhibited low adherence.
  • Low adherence was associated with lower quality-of-life scores, particularly in the physical and psychological domains.
  • Female sex, higher educational level, and recent diagnosis (1-3 years) were predictors of better adherence.
  • The study demonstrated the significance of adherence in CKD treatment, with potential implications for targeted interventions and patient well-being.

Sources:

  • Association between polypharmacy, medication adherence, and quality of life in patients with chronic kidney disease: a preliminary study in the Brazilian Amazon. O Mundo da Saude, 2025,49.
  • https://doi-org.sdpl.idm.oclc.org/10.15343/0104-7809.202549e17452025I
  • Centro Universitario Sao Camilo (publisher of O Mundo da Saude)
  • Universidade Federal do Para
  • Jaqueline da Trindade Valente
  • Maria Pantoja Moreira de Sena
  • Carolina Heitmann Mares Azevedo Ribeiro
  • Jose Luiz Fernandes Vieira
  • Luann Wendel Pereira de Sena

Read more